These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Path to approval proves rocky for copycat biodrugs. Wadman M Nature; 2005 Nov; 438(7065):154-5. PubMed ID: 16281004 [No Abstract] [Full Text] [Related]
3. Lessons from Eprex for biogeneric firms. Louët S Nat Biotechnol; 2003 Sep; 21(9):956-7. PubMed ID: 12949539 [No Abstract] [Full Text] [Related]
4. Sandoz sues FDA over delay in first biogeneric approval. Fox JL Nat Biotechnol; 2005 Nov; 23(11):1327-8. PubMed ID: 16273046 [No Abstract] [Full Text] [Related]
5. Biotechs go generic: the same but different. Ledford H Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194 [No Abstract] [Full Text] [Related]
7. Overcoming the obstacles in the pharma/biotech industry: 2008 update. Graul AI; Revel L; Rosa E; Cruces E Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298 [TBL] [Abstract][Full Text] [Related]
8. Why Genzyme can charge so much for Cerezyme. Anand G Wall St J (East Ed); 2005 Nov; ():A15. PubMed ID: 16502533 [No Abstract] [Full Text] [Related]
10. [Importance of quality in biotechnology: the case of the first biological similarity of erythropoietin]. Le Cotonnec JY; Lawny F Nephrol Ther; 2009 Feb; 5 Spec No1():10-5. PubMed ID: 19233077 [No Abstract] [Full Text] [Related]
13. Uncertain miracle: a biotech drug extends a life, but at what price? For Ms. Lees, treatment bill now totals $7 million; her bones keep crumbling; guilt of another $1,400 day. Wall St J (East Ed); 2005 Nov; ():A1, A15. PubMed ID: 16502532 [No Abstract] [Full Text] [Related]
14. Congress works to permit 'biosimilar' drugs very soon. Carroll J Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559 [No Abstract] [Full Text] [Related]
15. Meeting in the middle. Nature; 2007 Jun; 447(7145):629. PubMed ID: 17554281 [TBL] [Abstract][Full Text] [Related]
16. Pharmacologic chaperoning as a strategy to treat Gaucher disease. Yu Z; Sawkar AR; Kelly JW FEBS J; 2007 Oct; 274(19):4944-50. PubMed ID: 17894779 [TBL] [Abstract][Full Text] [Related]
17. Copycats gear up to dog biotech brands. Wadman M Nature; 2006 Oct; 443(7111):496-7. PubMed ID: 17024060 [No Abstract] [Full Text] [Related]
18. 1994 biotechnology drug approvals. Manuel SM Am Pharm; 1995 Mar; NS35(3):12-3. PubMed ID: 8533725 [No Abstract] [Full Text] [Related]
19. [Return the compass--but to whom?]. Onfelt C Tidsskr Nor Laegeforen; 2006 Feb; 126(5):636; author reply 636. PubMed ID: 16505885 [No Abstract] [Full Text] [Related]